ArticleFrontiers in psychiatry2025
Dose-response relationship between carotenoid intake and risk of depressive symptoms in postmenopausal women.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Skin Aging and Carotenoids: A Systematic Review of Their Multifaceted Protective Mechanisms.Nutrients · 2025Pooled it
- Dietary interventions and nutritional strategies for menopausal health: a mini review.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It is well known that postmenopausal women have an increased risk of depression, and there is a dose correlation between carotenoid intake and depression. However, there is no clear study on the relationship between carotenoids and the risk of depression in postmenopausal women. To evaluate the relationship between the prevalence of depression and carotenoid intake in postmenopausal women. Methods: The study was based on the National Health and Nutrition Examination Survey (NHANES) from 2013 to 2018 and included 1089 postmenopausal female participants. A logistic regression model was used to verify the relationship between carotenoid intake and the prevalence of depression in postmenopausal women. A restricted cubic spline (RCS) model was used to study the dose-response relationship between carotenoid intake and depression. Results: After adjusting for confounding variables, Odds Ratios (95% confidence intervals) were found for depression in the highest quartile compared with the lower quartile. Among them, the results of lutein zeaxanthin and β-cryptoxanthin were not statistically significant (P > 0.05). Total lycopene 0.29 (0.10,0.87), β-carotene 0.41 (0.18,0.94), and total carotenoid 0.25 (0.09,0.67) were negatively correlated with the risk of depression in postmenopausal women. When α-carotene intake exceeded 2.90 mg/day, it was negatively and non-linearly associated with the prevalence of depression in postmenopausal women (P-nonlinear < 0.0022). When β-carotene intake exceeded 1.06 mg/day, it was negatively correlated with the prevalence of depression in postmenopausal women. It had an L-type nonlinear relationship with the prevalence of depression (P-nonlinear < 0.0016). Total lycopene was linearly correlated with the prevalence of depression in postmenopausal women (P-nonlinear = 0.3). When the intake exceeded 2.05 mg/day, it was negatively correlated with the prevalence. Conclusion: The study found that dietary intake of sufficient α-carotene, β-carotene, lycopene, total lutein, and zeaxanthin was negatively correlated with the prevalence of depression in postmenopausal women. Still, there was no dose correlation between β-cryptoxanthin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.